Naifei Chen

2.0k total citations
54 papers, 1.3k citations indexed

About

Naifei Chen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Naifei Chen has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Naifei Chen's work include Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (11 papers) and RNA Research and Splicing (7 papers). Naifei Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (11 papers) and RNA Research and Splicing (7 papers). Naifei Chen collaborates with scholars based in China, United States and Norway. Naifei Chen's co-authors include Jiuwei Cui, Zheng Lv, Lingyu Li, Ji‐Fan Hu, Rilan Bai, Huimin Tian, Lei Zhou, Ling Bai, Wei Song and Lin Jia and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Naifei Chen

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naifei Chen China 16 748 585 411 297 185 54 1.3k
Helge Stenvold Norway 14 532 0.7× 503 0.9× 288 0.7× 162 0.5× 161 0.9× 17 907
Rei Mizuno Japan 17 509 0.7× 303 0.5× 454 1.1× 322 1.1× 122 0.7× 46 1.2k
Jason E. Toombs United States 21 554 0.7× 255 0.4× 542 1.3× 395 1.3× 130 0.7× 32 1.2k
Remi Adelaiye‐Ogala United States 14 563 0.8× 193 0.3× 356 0.9× 318 1.1× 312 1.7× 26 1.0k
Nicole E. Willmarth United States 17 671 0.9× 390 0.7× 496 1.2× 164 0.6× 139 0.8× 23 1.2k
Véronique Secq France 15 448 0.6× 251 0.4× 431 1.0× 278 0.9× 177 1.0× 41 1.1k
Weina Yu China 12 511 0.7× 294 0.5× 411 1.0× 449 1.5× 165 0.9× 20 1.2k
Claudia Felici Italy 15 534 0.7× 419 0.7× 357 0.9× 156 0.5× 125 0.7× 26 1.0k
Chitra Joseph United Kingdom 19 390 0.5× 262 0.4× 354 0.9× 159 0.5× 227 1.2× 36 923
Lesley Mathews United States 15 862 1.2× 374 0.6× 604 1.5× 159 0.5× 253 1.4× 21 1.4k

Countries citing papers authored by Naifei Chen

Since Specialization
Citations

This map shows the geographic impact of Naifei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naifei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naifei Chen more than expected).

Fields of papers citing papers by Naifei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naifei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naifei Chen. The network helps show where Naifei Chen may publish in the future.

Co-authorship network of co-authors of Naifei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Naifei Chen. A scholar is included among the top collaborators of Naifei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naifei Chen. Naifei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yang, et al.. (2025). Metabolic Vulnerability Index and Atherosclerosis Incident: A Prospective Cohort Study From the UK Biobank. Journal of the American Heart Association. 14(22). e043538–e043538.
2.
3.
Li, Yuguang, Yingrui Liu, Wei Song, et al.. (2025). Oxidative stress and retinopathy: evidence from epidemiological studies. Journal of Translational Medicine. 23(1). 94–94. 2 indexed citations
4.
Li, Yuguang, et al.. (2024). Association Between Cardiovascular Health and Retinopathy in US Adults: From NHANES 2005-2008. American Journal of Ophthalmology. 266. 56–67. 6 indexed citations
5.
Bai, Rilan, et al.. (2024). ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer. Molecular Carcinogenesis. 63(12). 2401–2413. 4 indexed citations
6.
7.
Bai, Rilan, et al.. (2024). Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant tumors. Chinese Journal of Cancer Research. 36(4). 421–441. 1 indexed citations
8.
Chen, Naifei, Chengfei Pu, Lingling Zhao, et al.. (2023). A phase 1 dose escalation study of GCC19CART: A novel coupled CAR therapy for patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). 3547–3547. 1 indexed citations
9.
Guo, Hanfei, Bin Wang, Wenqian Li, Naifei Chen, & Jiuwei Cui. (2023). Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases. 2(1).
10.
Guo, Hanfei, Wenqian Li, Ye Guo, Naifei Chen, & Jiuwei Cui. (2023). Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation. Chinese Medical Journal. 137(2). 130–139. 4 indexed citations
11.
12.
Bai, Rilan, Naifei Chen, Xiao Chen, et al.. (2021). Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events. Cancer Biology and Medicine. 18(4). 1118–1133. 27 indexed citations
13.
Bai, Rilan, Lingyu Li, Xiaohong Chen, et al.. (2020). Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer. Frontiers in Oncology. 10. 575472–575472. 45 indexed citations
14.
Wang, Wenjun, Lingyu Li, Naifei Chen, et al.. (2020). Nerves in the Tumor Microenvironment: Origin and Effects. Frontiers in Cell and Developmental Biology. 8. 601738–601738. 70 indexed citations
15.
Bai, Rilan, Naifei Chen, Lingyu Li, et al.. (2020). Mechanisms of Cancer Resistance to Immunotherapy. Frontiers in Oncology. 10. 1290–1290. 249 indexed citations
16.
Wang, Yang, Naifei Chen, Lingyu Li, et al.. (2020). <p>Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations</p>. PubMed. Volume 11. 59–71. 5 indexed citations
17.
Du, Zhonghua, Lin Jia, Yichen Wang, et al.. (2018). Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming. Scientific Data. 5(1). 180255–180255. 13 indexed citations
18.
Xue, Wen, Yuanyuan Nie, Zhonghua Du, et al.. (2018). Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition. Molecular Therapy — Nucleic Acids. 12. 105–117. 28 indexed citations
19.
Liu, Xiaoliang, Yehui Tan, Yu Liu, et al.. (2017). Immune re-constitution after allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies. 38(2). 70–77. 1 indexed citations
20.
Song, Wei, Na Wang, Wei Li, et al.. (2013). Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia. Oncology Letters. 6(5). 1453–1460. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helge Stenvold Breakdown of academic impact, for papers by Rei Mizuno Breakdown of academic impact, for papers by Jason E. Toombs Breakdown of academic impact, for papers by Remi Adelaiye‐Ogala Breakdown of academic impact, for papers by Nicole E. Willmarth Breakdown of academic impact, for papers by Véronique Secq Breakdown of academic impact, for papers by Weina Yu Breakdown of academic impact, for papers by Claudia Felici Breakdown of academic impact, for papers by Chitra Joseph Breakdown of academic impact, for papers by Lesley Mathews
Rankless by CCL
2026